Stephens Consulting’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$506K Hold
1,084
0.16% 34
2025
Q3
$462K Sell
1,084
-4
-0.4% -$1.55K 0.16% 36
2025
Q2
$417K Buy
1,088
+4
+0.4% +$1.44K 0.1% 68
2025
Q1
$375K Hold
1,084
0.09% 67
2024
Q4
$325K Hold
1,084
0.08% 78
2024
Q3
$441K Hold
1,084
0.11% 61
2024
Q2
$348K Hold
1,084
0.1% 65
2024
Q1
$362K Sell
1,084
-176
-14% -$53.8K 0.11% 63
2023
Q4
$341K Hold
1,260
0.12% 59
2023
Q3
$310K Hold
1,260
0.13% 60
2023
Q2
$382K Hold
1,260
0.15% 53
2023
Q1
$332K Hold
1,260
0.2% 58
2022
Q4
$302K Hold
1,260
0.2% 58
2022
Q3
$232K Hold
1,260
0.21% 64
2022
Q2
$212K Hold
1,260
0.17% 65
2022
Q1
$316K Sell
1,260
-15
-1% -$3.77K 0.26% 56
2021
Q4
$328K Buy
+1,275
New +$312K 0.27% 62

Other funds holding HCA

Stephens Consulting's HCA Position: Q4 2025 in Review

Stephens Consulting held its HCA Healthcare (HCA) position steady in Q4 2025 at 1,084 shares worth $506K. The position accounts for 0.16% of the portfolio, ranked #34.

Stephens Consulting first reported a position in HCA in Q4 2021 and has held it in 17 quarters since. 1,395 funds tracked by Wall St. Rank hold HCA as of Q4 2025.

  • Stephens Consulting held 1,084 shares of HCA Healthcare worth $506K as of Q4 2025.
  • Stephens Consulting left its HCA Healthcare share count unchanged in Q4 2025.
  • HCA Healthcare made up 0.16% of Stephens Consulting's portfolio in Q4 2025, its #34 holding.
  • Stephens Consulting first reported a position in HCA Healthcare in Q4 2021 and has held it in 17 quarters since.
  • 1,395 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2025.

Based on Stephens Consulting's 13F filing for Q4 2025, filed 13 Jan 2026.